scholarly journals OPERATING ON HEAD AND NECK CANCERS DURING COVID-19 PANDEMIC: OUR EXPERIENCE IN A TERTIARY CARE SURGICAL ONCOLOGY CENTER IN CENTRAL INDIA

2020 ◽  
pp. 72-73
Author(s):  
Sandeep Ghosh ◽  
Bonny Joseph ◽  
Vinod Dhakad ◽  
Sanjay Desai

WHO declared the COVID-19 outbreak to be a global pandemic on March 11, 2020. We hereby present the ongoing challenges, and the protocol and algorithms followed by us right from diagnosis, surgery and follow up of 50 head and neck cancer patients during the time of covid-19 pandemic at a tertiary care center in central India. Of the 50 head and neck cancer patients operated we had 16(32%) Ca buccal mucosa cases, 13(26%) cases of ca lower alveolus, 9 (18%) ca tongue cases, 5 (10%) ca maxilla, 3 (6%) ca larynx, 2 (4%) ca lip and 2 (4%) ca thyroid cases. It is prudent to consider every patient as covid carrier as community spread has already occurred in our country and take necessary precautions while examining all patients. Cancer Management is semi-emergency. The precautions taken by us are considered to be standard and have allowed us to perform head and neck cancer surgeries safely in this Covid-19 pandemic.

Author(s):  
N. Kavya Keerthika ◽  
D. Sri Veda ◽  
M. P. V. Prabhat ◽  
G. Sarat ◽  
Gunmeet Maini

Background: The occurrence of the head and neck cancers (HNC) is increasing day by day. These have been associated with multiple etiological factors, and early diagnosis has a prime role in the patient's prognosis and overall survival. Prognostic evaluation in head and neck cancer patients utilizing clinical incidence and imaging outcomes.Methods: The study sample included 217 confirmed HNC patients’ data obtained from the tertiary cancer care centre were analysed to assess the prognosis and be subjected to statistical analysis.Results: Out of all HNC, cancer pertaining to the lip and oral cavity was the most common variety with 65.89% and most of the HNC occurred in men of about 97%, suggesting a strong association with adverse oral habits.Conclusions: We conclude that the current scenario of HNC’s progression and treatment modalities in Andhra Pradesh were in comparison to the World Health Organization (WHO) data suggests an increase in the awareness of the etiological factors and the disease progression. Though various advanced imaging and treatment modalities are available, the patients' prognosis is untethered due to low socio-economic status in this region.


Author(s):  
Surender Kumar ◽  
Neha Salaria ◽  
Deepak Verma ◽  
Uma Garg ◽  
Monika Verma

Background- Head and neck squamous cell carcinomas(HNSCC) are one of the most widespread malignancies worldwide. Trace elements such as magnesium are essential at cellular level, and it has been suggested that magnesium plays a role in carcinogenesis. Methods- A hospital based case control study was conducted in a tertiary care medical college with an aim to determine the levels of serum magnesium in patients with head and neck cancer and to  compare  the  levels  of  serum  magnesium  of head and neck cancer patients   with healthy matched control  group  and  derive significance if any. Results- HNSCC was mainly found in males of age group 46 to 55 years. The mean serum Mg value of head and neck cancer patients was 0.71± 0.18 mmol/l while that seen in controls was 0.85± 0.09 mmol/l which was significantly lower(p<0.001). Average serum magnesium levels in stages I, II, III and IV were 0.85, 0.849, 0.682 and 0.554 mmol/l respectively, and a statistically significant association was determined between the two. Conclusion- As the stage of cancer progressed, average magnesium levels decreased congruently, hence establishing that magnesium levels were undeniably correlated to onset as well as progression of HNC. These evidences could be utilized to identify role of magnesium asa potential prognostic biomarker to assess progression of disease or clinical response to various modes of therapy in head and neck cancer patients.


2008 ◽  
Vol 100 (6) ◽  
pp. 690-697 ◽  
Author(s):  
Bukola F Adeyemi ◽  
Lola V Adekunle ◽  
Bamidele M Kolude ◽  
Effiong E.U. Akang ◽  
Jonathan O. Lawoyin

2021 ◽  
Vol 5 (4) ◽  
pp. 166-170
Author(s):  
Talha Ahmed Qureshi ◽  
◽  
Shabir Akhtar ◽  
Sohail Awan ◽  
Amir Sharif ◽  
...  

Abstract: Objective: The current study was conducted to review and compare PEG and Gastrostomy in terms of early complications in head and neck cancer patients. Materials and Methods: This was prospective comparative study recruited total 60 patients as per the inclusion criteria, 30 in each group. Patients were assigned to the groups based on the surgeon’s choice. Ethical clearance was taken from ethical review board. Informed consent was taken from patients before enrolling them into the study. Non-probability consecutive sampling technique was used to enroll study participants. Data was collected on pre-designed performa and analyzed using SPSS version 16. Setting: Section of Otolaryngology, Department of Surgery, Aga Khan University Hospital Karachi. Results: The two groups did not differ on basis of age, gender and tumor site. The outcomes variables including pain and bleeding from post-operative day1 to day 5 were significantly lower in patients who underwent PEG placement as compared to patients whom we performed OPEN gastrostomy. None the patient had peristomal infection in PEG group throughout the study. However, difference between the groups was statistically significant from post-operative day 3 to day 5. Conclusion: In our study, PEG was associated with lesser complications than open gastrostomy. Recently clinicians are using newer modalities like radiological and laparoscopic gastrostomy at various centres in Pakistan as the first option for placing feeding gastrostomy. Therefore, future studies are warranted to compare their efficacy and post-operative complications PEG. Keywords: Head and neck cancer, Open gastrostomy, Percutaneous endoscopic gastrostomy, Complications, Pain, Peristomal infection, Bleeding


Oral Oncology ◽  
2021 ◽  
Vol 118 ◽  
pp. 2
Author(s):  
André Laranja ◽  
Diana Moreira ◽  
Isabel Reis ◽  
Isabel Rodrigues ◽  
Fausto Sousa ◽  
...  

2019 ◽  
Vol 133 (05) ◽  
pp. 424-429 ◽  
Author(s):  
E Kytö ◽  
E Haapio ◽  
H Minn ◽  
H Irjala

AbstractObjectiveHead and neck cancer follow-up length, interval and content are controversial. Therefore, this study aimed to evaluate the efficacy of the follow-up protocol after curative treatment in head and neck cancer patients.MethodClinical data of 456 patients with new malignancy of the head and neck from a tertiary care centre district from 1999 to 2008 were analysed. Time from treatment, symptoms and second-line treatment outcomes of patients with recurrent disease were evaluated.ResultsA total of 94 (22 per cent) patients relapsed during the 5-year follow-up period; 90 per cent of recurrences were found within 3 years. Fifty-six per cent of the patients had subjective symptoms indicating a recurrence of the tumour. All recurrent tumours found during routine follow-up visits without symptoms were found within 34 months after completion of treatment.ConclusionRoutine follow up after three years is questionable; recurrent disease beyond this point was detected in only 2 per cent of patients. In this study, all late tumour recurrences had symptoms of the disease. Easy access to extra follow-up visits when symptoms occur could cover the need for late follow up.


2016 ◽  
Vol 130 (S2) ◽  
pp. S66-S67 ◽  
Author(s):  
C Nutting

AbstractThis is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. Radiotherapy is one of the key treatment modalities used in head and neck cancer management. This paper summarises the current role and some of the recent advances in radiotherapy in head and neck cancer management.


2016 ◽  
Vol 130 (S2) ◽  
pp. S71-S74 ◽  
Author(s):  
C G Kelly

AbstractThis is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. This paper summarises the role of chemotherapy in head and neck cancer management, recent advances and what the future holds for this modality.


2021 ◽  
Vol 11 ◽  
Author(s):  
Connor L. Pratson ◽  
Michael C. Larkins ◽  
Brandon H. Karimian ◽  
Caitrin M. Curtis ◽  
Pamela A. Lepera ◽  
...  

There is a paucity of information regarding the demographic factors associated with the development of neck fibrosis in head and neck cancer (HNC) patients following radiotherapy. A retrospective review of all patients being treated for HNC at a tertiary care center between 2013 and 2017 was performed. Chi-squared and Mann-Whitney U tests were used to identify differences in incidence and grade of fibrosis, respectively, between populations. A total of 90 patients aged 19 to 99 years were included. Factors associated with an increased incidence of fibrosis included smoking during radiotherapy (p &lt; 0.001), alcohol use (p = 0.026), recurrent disease (p = 0.042), and age less than 60 (p &lt; 0.001) on univariate analysis. Factors associated with increased grade of fibrosis in HNC patients included recurrent HNC (p = 0.033), alcohol use (p = 0.013), patient age younger than 60 years (p = 0.018), smoking during radiotherapy (p &lt; 0.001), and non-Caucasian race (p = 0.012). Identification and intervention directed at patients that possess risk factors associated with fibrosis prior to treatment has the potential to improve the long-term quality of life for HNC patients.


2016 ◽  
Vol 156 (1) ◽  
pp. 118-121 ◽  
Author(s):  
Sumi Sinha ◽  
Sidharth V. Puram ◽  
Rosh K. V. Sethi ◽  
Neerav Goyal ◽  
Kevin S. Emerick ◽  
...  

Patients with head and neck cancer who undergo reconstructive surgery are at risk for deep venous thrombosis (DVT), but the risk profile for patients undergoing major flap reconstruction is highly variable. Herein, we report our findings from a retrospective analysis of head and neck cancer patients (n = 517) who underwent free (n = 384) or pedicled (n = 133) flap reconstructive operations at a major tertiary care center from 2011 to 2014. DVTs developed perioperatively in 9 (1.7%) patients. Compared with pedicled flap patients, free flap patients had a longer mean operative time (421.4 ± 4.4 vs 332.7 ± 10.7 min, P < .0001), but the DVT incidence did not differ significantly between free and pedicled flap patients (1.6% vs 2.2%, respectively, P = .28). These data suggest that perioperative DVT risk in head and neck oncology patients may be largely similar regardless of the reconstructive strategy pursued.


Sign in / Sign up

Export Citation Format

Share Document